Longevity Health Holdings, Inc.
XAGE
$0.21
-$0.01-5.83%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 60.33% | 220.01% | 3,702.98% | 4,343.29% | -71.88% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 60.33% | 220.01% | 3,702.98% | 4,343.29% | -71.88% |
| Cost of Revenue | 226.06% | 229.98% | 11,066.67% | 9,423.53% | 98,500.00% |
| Gross Profit | -4.51% | 212.21% | 2,648.18% | 3,407.58% | 6,200.83% |
| SG&A Expenses | 16.77% | 61.16% | 88.65% | 42.08% | 54.32% |
| Depreciation & Amortization | -26.27% | -16.81% | -5.52% | -8.69% | -11.94% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.87% | 54.88% | 76.40% | 64.60% | 32.81% |
| Operating Income | -7.58% | -36.81% | -39.90% | -32.15% | -12.21% |
| Income Before Tax | 6.74% | 21.90% | 36.09% | 40.14% | 54.27% |
| Income Tax Expenses | 137.31% | 137.31% | 137.31% | -- | -- |
| Earnings from Continuing Operations | 4.97% | 20.60% | 35.16% | 41.14% | 54.88% |
| Earnings from Discontinued Operations | -- | -- | -- | -100.00% | -100.00% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.97% | 20.60% | 33.40% | 8.90% | 51.72% |
| EBIT | -7.58% | -36.81% | -39.90% | -32.15% | -12.21% |
| EBITDA | -8.08% | -37.70% | -40.68% | -33.00% | -12.66% |
| EPS Basic | 58.80% | 63.30% | 65.02% | 43.00% | 63.85% |
| Normalized Basic EPS | 62.38% | 63.80% | 66.61% | 61.17% | 63.05% |
| EPS Diluted | 58.80% | 63.30% | 65.02% | 43.00% | 63.85% |
| Normalized Diluted EPS | 62.38% | 63.80% | 66.61% | 61.17% | 63.05% |
| Average Basic Shares Outstanding | 119.34% | 115.18% | 100.46% | 57.49% | 25.75% |
| Average Diluted Shares Outstanding | 119.34% | 115.18% | 100.46% | 57.49% | 25.75% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |